Shi R, Sun J, Zhou Z, Shi M, Wang X, Gao Z
NPJ Precis Oncol. 2025; 9(1):54.
PMID: 40011681
PMC: 11865301.
DOI: 10.1038/s41698-025-00842-8.
Xu X, Fei X, Wang H, Wu X, Zhan Y, Li X
Gut Microbes. 2025; 17(1):2463581.
PMID: 39924917
PMC: 11812335.
DOI: 10.1080/19490976.2025.2463581.
Zhang D, Chen T
J Gastrointest Cancer. 2025; 56(1):56.
PMID: 39875748
DOI: 10.1007/s12029-025-01181-4.
Cho Y, Ahn S, Kim K
J Gastric Cancer. 2025; 25(1):177-191.
PMID: 39822174
PMC: 11739645.
DOI: 10.5230/jgc.2025.25.e4.
Qu F, Wu S, Yu W
Onco Targets Ther. 2024; 17:1223-1253.
PMID: 39735789
PMC: 11681808.
DOI: 10.2147/OTT.S500281.
Next-generation sequencing in the molecular classification of endometrial carcinomas: Experience with 270 cases suggesting a potentially more aggressive clinical behavior of multiple classifier endometrial carcinomas.
Michalova K, Strakova-Peterikova A, Ondic O, Vanecek T, Michal M, Hejhalova N
Virchows Arch. 2024; .
PMID: 39676078
DOI: 10.1007/s00428-024-03996-1.
Mapping the Future: A Comprehensive Bibliometric Analysis of Circulating Tumor DNA in Colorectal Cancer.
Wang C
J Multidiscip Healthc. 2024; 17:5473-5486.
PMID: 39600714
PMC: 11590644.
DOI: 10.2147/JMDH.S493863.
Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan.
Hida T, Idogawa M, Kato J, Kiniwa Y, Horimoto K, Sato S
Cancer Med. 2024; 13(22):e70360.
PMID: 39564955
PMC: 11577301.
DOI: 10.1002/cam4.70360.
Genomic instability as a driver and suppressor of anti-tumor immunity.
Requesens M, Foijer F, Nijman H, de Bruyn M
Front Immunol. 2024; 15:1462496.
PMID: 39544936
PMC: 11562473.
DOI: 10.3389/fimmu.2024.1462496.
Companion diagnostics and predictive biomarkers for PD-1/PD-L1 immune checkpoint inhibitors therapy in malignant melanoma.
Wang Z, Zou X, Wang H, Hao Z, Li G, Wang S
Front Immunol. 2024; 15:1454720.
PMID: 39530091
PMC: 11550933.
DOI: 10.3389/fimmu.2024.1454720.
[Research Progresses on the Effects of CCL4 on Immune Escape
in Tumor Microenvironment].
Chen R, Yang X, Liu Q, Zhang S, Ma L
Zhongguo Fei Ai Za Zhi. 2024; 27(8):613-621.
PMID: 39318254
PMC: 11425676.
DOI: 10.3779/j.issn.1009-3419.2024.106.23.
Proteomic Investigation of Immune Checkpoints and Some of Their Inhibitors.
Agostini M, Traldi P, Hamdan M
Int J Mol Sci. 2024; 25(17).
PMID: 39273224
PMC: 11395526.
DOI: 10.3390/ijms25179276.
Epigenetics and immunotherapy in colorectal cancer: progress and promise.
Dang T, Guan X, Cui L, Ruan Y, Chen Z, Zou H
Clin Epigenetics. 2024; 16(1):123.
PMID: 39252116
PMC: 11385519.
DOI: 10.1186/s13148-024-01740-9.
A phase II clinical trial of toripalimab in advanced solid tumors with polymerase epsilon/polymerase delta (POLE/POLD1) mutation.
Jin Y, Huang R, Guan W, Wang Z, Mai Z, Li Y
Signal Transduct Target Ther. 2024; 9(1):227.
PMID: 39218995
PMC: 11366758.
DOI: 10.1038/s41392-024-01939-5.
Recent developments in immunotherapy for gastrointestinal tract cancers.
Chong X, Madeti Y, Cai J, Li W, Cong L, Lu J
J Hematol Oncol. 2024; 17(1):65.
PMID: 39123202
PMC: 11316403.
DOI: 10.1186/s13045-024-01578-x.
Efficacy and safety of PD-1/L1 inhibitors as first-line therapy for metastatic colorectal cancer: a meta-analysis.
Huang Z, Li C, Huang Y, Liang W, Tao H
Front Immunol. 2024; 15():1425596.
PMID: 39100666
PMC: 11294095.
DOI: 10.3389/fimmu.2024.1425596.
Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?.
Hamid M, Pammer L, Lentner T, Doleschal B, Gruber R, Kocher F
Curr Oncol Rep. 2024; 26(10):1258-1270.
PMID: 39080202
PMC: 11480176.
DOI: 10.1007/s11912-024-01583-w.
Clinical practice recommendations for the use of next-generation sequencing in patients with solid cancer: a joint report from KSMO and KSP.
Kim M, Shim H, Kim S, Lee I, Kim J, Yoon S
J Pathol Transl Med. 2024; 58(4):147-164.
PMID: 39026440
PMC: 11261170.
DOI: 10.4132/jptm.2023.11.01.
Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring.
Tao X, Li Q, Zeng Y
Mol Cancer. 2024; 23(1):145.
PMID: 39014366
PMC: 11250976.
DOI: 10.1186/s12943-024-02063-2.
CSCO guidelines for colorectal cancer version 2024: Updates and discussions.
Chen L, Hu H, Yuan Y, Weng S
Chin J Cancer Res. 2024; 36(3):233-239.
PMID: 38988483
PMC: 11230882.
DOI: 10.21147/j.issn.1000-9604.2024.03.01.
